The global pediatric diabetes therapeutic market, valued at USD 9.80 billion in 2024, is set to grow at a robust compound annual growth rate (CAGR) of 13.5% from 2025 to 2034, reaching a projected revenue of USD 34.60 billion by 2034. This significant expansion is fueled by rising diabetes prevalence in children, improved disease awareness, and advancements in...